Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP339745.RAPHdt-81SAr-6-dE4Drqxp7NPIBG0fXbViuYmSsdXeo4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP339745.RAPHdt-81SAr-6-dE4Drqxp7NPIBG0fXbViuYmSsdXeo4130_assertion type Assertion NP339745.RAPHdt-81SAr-6-dE4Drqxp7NPIBG0fXbViuYmSsdXeo4130_head.
- NP339745.RAPHdt-81SAr-6-dE4Drqxp7NPIBG0fXbViuYmSsdXeo4130_assertion description "[In the 22q11.2 deletion syndrome group, baseline subthreshold psychotic symptoms interacted both with the COMT genotype and with baseline symptoms of anxiety or depression to predict 61% of the variance in severity of psychosis at follow-up evaluation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP339745.RAPHdt-81SAr-6-dE4Drqxp7NPIBG0fXbViuYmSsdXeo4130_provenance.
- NP339745.RAPHdt-81SAr-6-dE4Drqxp7NPIBG0fXbViuYmSsdXeo4130_assertion evidence source_evidence_literature NP339745.RAPHdt-81SAr-6-dE4Drqxp7NPIBG0fXbViuYmSsdXeo4130_provenance.
- NP339745.RAPHdt-81SAr-6-dE4Drqxp7NPIBG0fXbViuYmSsdXeo4130_assertion SIO_000772 17403981 NP339745.RAPHdt-81SAr-6-dE4Drqxp7NPIBG0fXbViuYmSsdXeo4130_provenance.
- NP339745.RAPHdt-81SAr-6-dE4Drqxp7NPIBG0fXbViuYmSsdXeo4130_assertion wasDerivedFrom befree-20140225 NP339745.RAPHdt-81SAr-6-dE4Drqxp7NPIBG0fXbViuYmSsdXeo4130_provenance.
- NP339745.RAPHdt-81SAr-6-dE4Drqxp7NPIBG0fXbViuYmSsdXeo4130_assertion wasGeneratedBy ECO_0000203 NP339745.RAPHdt-81SAr-6-dE4Drqxp7NPIBG0fXbViuYmSsdXeo4130_provenance.